FEATURED COMPANY

QUOTEMEDIA INC. (OTCBB: QMCI)

Detailed Quote: http://www.otcpicks.com/quotes/QMCI.php

Company Profile: http://www.otcpicks.com/quotemedia/quotemedia.htm

QuoteMedia, Inc. is a leading software developer and provider of real-time streaming financial market information, decision-support, news and research solutions to brokerage, financial services companies, business and media corporations. Among its many leading-edge products lines, the Company offers data feeds, news, dynamic market content solutions, interactive stock research tools, financial applications and real-time wireless applications. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Forbes.com, Scotia Capital, Business Wire, Southwest Securities, Regal Securities, FBR Direct, Broadridge Financial Solutions, Inc., AIM Trimark, Zacks Investment Research, ChoiceTrade, QTrade, Schaeffer's Investment Research, Automated Financial Systems, WallStreet*E, and others. For more information, visit www.quotemedia.com.

QMCI News:

May 15 - QuoteMedia Reports 45% Increase in Revenue for Q1 2008

QuoteMedia, Inc. (OTCBB: QMCI), a leading provider of market data and financial applications, announced financial results for the three months ended March 31, 2008. These results reflect a 45% increase in first quarter revenues, to $1,687,675 from $1,160,700 in the comparative period in 2007.

“The significant revenue growth during the quarter resulted from increased sales of our Interactive Content and Data Applications as well as from increased subscriptions to our Quotestream products,” says Keith Guelpa, president of QuoteMedia, Inc. “This is our 20th consecutive quarter of revenue growth, reflecting the strong continuing market penetration of our full line of financial data products and the increasing depth of our data offerings, which now cover over 70 exchanges worldwide. We expect that our customer base will continue to expand dramatically and our trend of strong revenue increases, quarter over quarter, to continue into the foreseeable future.”

“During the first quarter, QuoteMedia built on the momentum that was increasingly established during 2007. During the quarter, we continued to introduce Quotestream II to the market in limited, but increasing release. Quotestream II represents a new generation of our portfolio management system, with enhanced features and functionality. The Company also commenced limited release of Quotestream Professional which was substantially completed during 2007. Where Quotestream II is geared towards providing a professional level experience to non-professional users, Quotestream Professional is designed specifically for use by financial services professionals, offering unparalleled functionality at extremely aggressive pricing.”

“We remain focused on our revenue growing strategies,” says Guelpa. “Our plan of operation for the remainder of 2008 will center on marketing Quotestream II for deployments by brokerage firms to their clients, and moving strongly into the investment professional market with Quotestream Professional. We also plan to release additional international data sets and continue the market penetration of our Data Feed Services. We will continue to license our Quotestream Wireless applications and add new data content to expand our line of Interactive Content and Data Applications.”

“As previously forecasted, and consistent with our focus on expansion, we experienced a loss for the quarter of $354,919 compared to a loss of $372,085 in the comparative period. While we expect that we will continue to incur losses in the short term, we expect our revenues will continue to rise significantly in 2008 and overtake the increased cost commitments that we have undertaken to support our rapid development. Our improvement in gross margin rate to 58% compared to 56%, in the first quarter of 2007, reflects the stabilization of our fixed cost structures as revenues continue to increase. We expect our costs of revenue to continue to reduce as a percentage of revenues generated. We are very pleased with our progress to date, and we believe that we are on target to meet our near and long term objectives,” says Guelpa.

FEATURED COMPANY

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)

Detailed Quote: http://www.otcpicks.com/quotes/MGRN.php

Company Profile:
http://www.otcpicks.com/monogram-energy/monogram-energy.htm

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

MGRN News:

May 13 - Monogram Energy Inc. Continues to Produce in Corsicana, Texas

Monogram Energy, Inc. (OTC: MGRN), an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties, announced that the Company will begin workovers on 3 additional wells early next week in Corsicana, Texas. These wells are part of the T.W. Martin lease and are expected to produce an estimated 270 barrels a month. The workover is expected to take one week to complete and will increase the total number of wells in production to eight. The T.W. Martin lease comprises 70 acres with 12 wells and is located in Navarro County, which produces around 600,000 barrels annually.

"These next three wells should provide us with some nice operating cash flow," stated Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc. Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.

FEATURED COMPANY

CARBON SCIENCES INCORPORATED (OTCBB: CABN)
"Up 10.53% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CABN.php

Company Profile:
http://www.otcpicks.com/carbon-sciences/carbon-sciences-2.htm

Carbon Sciences, Inc. focuses on developing GreenCarbon technology to convert carbon dioxide into a form that would not contribute to global warming. Its GreenCarbon technology is targeted at coal-fired electrical power plants and fuel production plants. The company was founded in 2006 as Zingerang, Inc. and changed its name to Carbon Sciences, Inc. in April 2007. Carbon Sciences, Inc. is based in Santa Barbara, California.

CABN News:

May 12 - Carbon Sciences Targets Near Term Multi-Billion Dollar Market for Its CO2 Transformation Technology

Carbon Sciences, Inc. (OTCBB: CABN), the developer of a breakthrough technology to transform harmful carbon dioxide (CO2) into high value, earth-friendly products, today announced its first application targeting a near term multi-billion dollar global market.

This initial application of the Company's technology is a process that will transform CO2 into a high value chemical compound, currently used in the manufacture of paper, pharmaceuticals and plastics. Unlike existing methods of production, Carbon Sciences' clean tech process will be carbon neutral, use less energy and result in a lower cost product.

The demand for this high value chemical compound (Precipitated Calcium Carbonate or "PCC") is projected to grow to 10 million tons by 2010, due to increased global paper consumption and construction in Asian countries. Of the forecasted total, approximately 70% of the PCC produced is expected to be used by the paper industry as brightness coating and filler.

The Company's management believes that energy and CO2 intensive industries, such as paper production, will welcome this innovative clean technology because it offers two very important benefits — lower cost and carbon neutrality. For example, a paper mill with an integrated PCC plant, based on the Company's proprietary technology, will be able to transform its own CO2 emissions into PCC for immediate use in paper production — thereby decreasing cost and CO2 emissions.

Commenting on Carbon Sciences' go-to-market strategy, Derek McLeish, the Company's CEO, said, "We are excited that the PCC market provides us with a lucrative near term opportunity. While the massive market for CO2 mitigation in coal-fired power plants may be years away, the multi-billion dollar PCC market is here and now."

Mr. McLeish further stated, "According to the International Energy Agency, the CO2 mitigation technology market is projected to reach $400 billion by 2030. In April 2008, for the first time in history, President Bush unveiled a climate change proposal suggesting that the U.S. would accept binding cuts on CO2 emissions and calling for a peak by 2023, starting with the power generation industry. We believe that by focusing our efforts on the existing multi-billion dollar PCC industry, we will be well positioned to be a major player in the even larger $400 billion CO2 mitigation market in the future. This strategy is in line with our corporate mission of enabling a carbon neutral world by transforming CO2 into high value products, one industry at a time."

FEATURED COMPANY

BIOSOLAR INCORPORATED (OTC: BSRC)

Detailed Quote: http://www.otcpicks.com/quotes/BSRC.php

Company Profile: http://www.otcpicks.com/biosolar/biosolar-2.htm

BioSolar, Inc. engages in the research and development of bioplastic materials from renewable plant sources for use in photovoltaic solar cells. The company develops bio-based plastics components that meet the thermal and durability requirements of solar cell manufacturing processes for conventional crystalline cell designs, as well as thin film photovoltaic devices in an effort to capitalize on cost advantages to current petroleum based solar cell components. Its bioplastic materials can be also used directly in conventional manufacturing systems, such as injection molding and thin-film roll-to-roll, to create superstrate layer, substrate layer, and backsheet, as well as module and panel components. The company was founded in April 2006. It was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. is headquartered in Santa Clarita, California.

BSRC News:

May 13 - BioSolar Files Quarterly Report with SEC

Cash Flow Increases by 36%

BioSolar Inc. (OTC: BSRC) announced its results of operations for the quarter ended march 31, 2008 compared to the quarter ended march 31, 2007:

OPERATING EXPENSES

Selling and Marketing Expenses

Selling and marketing ("S&M") expenses increased by $37,894 or 368.48%, to $48,178 for the three months ended March 31, 2008, compared to the prior period. S&M expenses increased due to an increase in marketing exposure.

General and Administrative Expenses

General and administrative ("G&A") expenses increased by $39,560 or 46.23%, to $125,126 for the three months ended March 31, 2008, compared to the prior period. This increase in G&A expenses was the result of an increase in salaries and professional fees.

Research and Development

Research and Development ("R&D") expenses increased by $6,337or 23.22%, to $33,628 for the three months ended March 31, 2008, compared to the prior period. This increase in R&D expenses was the result of fees paid to consultants and testing of product.

Net Loss

Our net loss increased by $87,755 to $198,634 for the three months ended March 31, 2008, compared to the prior period. Currently the Company is in its development stage and had no revenues.

LIQUIDITY AND CAPITAL RESOURCES

As of March 31, 2008, we had $854,042 of working capital as compared to $1,064,076 as of December 31, 2007. This decrease of $210,034 was due primarily to use of funds for general and administrative expenses.

Cash flow used in operating activities was $217,228 for the three months ended March 31, 2008, as compared to cash used of $159,555 for the prior period. This increase of $57,673 was primarily attributable to an increase in research and development, and general and administrative expenses.

Cash used by investing activities was $7,258 for the three months ended March 31, 2008, as compared to cash used of $12,212 for the prior period. The decrease of cash used in investing activities was primarily due to a decrease in investing in certificates of deposits.

Cash provided from financing activities during the three months ended March 31, 2008, and 2007 was $0 respectively. There was no equity financing this period.

PLAN OF OPERATION AND FINANCING NEEDS

We are engaged in the development of new and innovative technology to produce bio-based materials with the intent to reduce the cost per watt of solar cells that convert sun light into electrical energy. We plan to develop bio-based backsheets, substrates, superstrate layer, module, panel components, and thereafter focus our efforts on establishing markets in the building materials.

Our plan of operation within the next twelve months is to utilize our cash balances to transition from research and development stage to a production stage for the bio-based plastic backsheets and substrates to reduce the cost of solar cells that convert sun light into electrical energy. In addition, during the next twelve months we plan to accelerate the development activity for other solar cell components, commence a test program to determine the physical properties and characteristics that will be most suitable for commercially available solar cell devices, and build prototype solar cells, as we attempt to validate the commercial viability of additional bio-based solar cell components. We believe that our current cash and investment balances will be sufficient to support development activity and general and administrative expenses for the next twelve months. Management estimates that it will require additional cash resources during 2008, based upon its current operating plan and condition. We will be investigating additional financing alternatives, including equity and/or debt financing. There is no assurance that capital in any form would be available to us, and if available, on terms and conditions that are acceptable. If we are unable to obtain sufficient funds during the next twelve months, we may be forced to reduce the size of our organization, which could have a material adverse impact on, or cause us to curtail and/or cease, the development of our products.

FEATURED COMPANY

KCM HOLDINGS CORPORATION (OTC: KCMH)

Detailed Quote: http://www.otcpicks.com/quotes/KCMH.php

Company Profile:
http://www.otcpicks.com/kcm-holdings/kcm-holdings-2.htm

KCM Holdings Corporation is a strategic business development and holdings company specializing in a broad range of business incubation, support, design and development ventures. For more information, visit www.thekcmgroup.com.

KCMH News:

May 9 - KCM Holdings Corp. Announces First Operational Quarter a Profitable Success and Unveils Recession Proofing Plan Projecting $3-7 Million in Revenue

KCM Holdings Corp. (OTC: KCMH), a strategic business development and holdings company, announced its results for the first quarter ending March 31, 2008.

For the first quarter of fiscal 2008, its first operational quarter as a publicly traded company, KCMH reported total revenue of $290,000 and net income of $160,000 after taxes. KCMH has already surpassed last quarter’s revenues in this fiscal quarter and projects even further growth.

“We realize it is rare that a micro-cap company shows profit its first quarter, so I am very pleased,” states Donald Klein, President and CEO.

According to Mr. Klein, "We accomplished our goal of diversifying into a range of industries based on globalization and recent interventions by the Government with financial institutions. We have identified a recession proofing strategy and supporting revenue models. Our focus will be on information and content-driven models like Google, and strong financial management similar to Goldman Sachs. Our goal is to bring the same strategies utilized by these great companies to the micro-cap arena, and with persistence and integrity, generate healthy revenue, even in the midst of today’s economic instability.”

Ed Kang, COO, was equally pleased and is confident operational revenues will continue to improve due to the internal recession proofing plan, “Our first quarter proves that our strategy is the right foundation for continual focus on conserving cash, core competencies, and expansion by creating proprietary value and innovative financial models.”

KCMH estimates its preliminary revenue projections between $3-7 Million in gross revenue for 2008. These preliminary projections are based on its current client schedule, revenue sharing agreements, acquisition negotiations and launching of additional publicly traded companies. KCMH is set to release its proprietary intellectual properties for small businesses this quarter and announce some key client agreements to assist in global expansion.

KCMH will shortly release its financials, un-audited, and with more details of its recession proofing plan on its website at www.theKCMgroup.com.

STOCKS TO WATCH

IDM PHARMA INCORPORATED (NASD: IDMI)
"Up 3.32% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/IDMI.php

IDM Pharma, Inc., a biopharmaceutical company, engages in the development of products to treat and control cancer. It develops product candidates to destroy residual cancer cells and to stimulate an immune response and prevent tumor recurrence. The company's products include L-MTP-PE/MEPACT, a Phase 3 clinical trial completed liposomal muramyl-tripeptide phosphatidylethanol- amine, for the treatment of osteosarcoma; BEXIDEM, a Phase 2 clinical trial completed product for the treatment of bladder cancer; UVIDEM, a Phase 2 clinical trial dendritophage and melanoma tumor cell lysates product, for the treatment of melanoma; IDM-2101, a multiple tumor-associated CTL epitopes Phase 2 clinical trial product, for the treatment of non-small cell lung cancer; and COLLIDEM, a Phase 1/2 dendritophages and tumor associated antigen peptides product, for the treatment of colorectal cancer. It has operations in the United States and France. IDM Pharma has collaboration agreements with sanofi-aventis S.A; Medarex, Inc.; GenPharm International, Inc.; Novartis; and Biotecnol S.A. It also has intellectual property licensing and framework agreement with Institut de Recherche Pierre Fabre and Pierre Fabre Medicament S.A. The company was incorporated in 1987 and is based in Irvine, California.

IDMI News:

May 15 - IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program

Data Presented at the 21st Annual Meeting of The American Society of Pediatric Hematology/Oncology (ASPHO) Meeting

IDM Pharma, Inc. (NASD: IDMI) (the “Company”) announced the presentation of updated data from a compassionate access program evaluating mifamurtide (L-MTP-PE) in patients with lung metastases as a result of the progression of osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults. The data show that L-MTP-PE in combination with other therapies is safe, well- tolerated and exhibited signs of disease control.

The compassionate access program provides L-MTP-PE treatment to patients who have either failed or cannot tolerate treatment with existing therapies compared to the Phase 3 pivotal study, which evaluated newly diagnosed patients.

"The results that we have seen to date from the Phase 3 clinical trial in patients with non-metastatic osteosarcoma are being supported in patients with lung metastases as the L-MTP-PE compassionate access experience continues to be encouraging," said Peter Anderson, M.D., Ph.D., principal investigator and professor of pediatrics, Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center in Houston. "With a formalized protocol now in place, we can address the increasing number of requests for compassionate access to L-MTP-PE and meet the unmet needs of certain patients by providing this much needed treatment option."

Study Design and Findings

Twenty-nine high-risk osteosarcoma patients (ages 10 - 21) were enrolled and 27 have been treated with L-MTP-PE in the compassionate access program to date (May 8, 2008). Patients in the program had documented diagnosis of high grade osteosarcoma with relapsed or recurrent disease (locally or metastatic) with resectable or not completely resectable disease, or who are unable to complete recommended chemotherapy due to toxicity.

L-MTP-PE (2 mg/m2 IV over 1 hour) was administered twice a week for 12 weeks followed by once a week for 24 weeks. In addition, some patients in the program were also treated with other agents including aerosol recombinant granulocyte monocyte colony stimulating factor (GM-CSF) an immune stimulating agent (n=20), ifosfamide (n=4), and/or gemcitabine (n=2).

Results to date are as follows:

* Nine patients are alive with disease.
* Nine patients have no evidence of disease.
* Nine patients have died.
* There are two patients for whom the status is unknown.

Treatment with L-MTP-PE combined with other agents including aerosol GM- CSF was generally well tolerated. Patients treated with chemotherapy had no unexpected toxicities and toxicity from L-MTP-PE infusions was minimal. There were no reports of grade 3 or 4 drug-related toxicities with the exception of fever grade 3 and flu-like symptoms with the first dose. This was prevented with ibuprofen and acetaminophen after subsequent doses. One patient developed pleural and pericardial effusion that was possibly L-MTP-PE and/or GM-CSF related and the patient was removed from the study.

In March, the Company announced that it had formalized a clinical protocol with the FDA, which provides L-MTP-PE to eligible, high-risk osteosarcoma patients through a compassionate access study. The compassionate access study is being conducted initially at M. D. Anderson and Memorial-Sloan Kettering Cancer Center in New York.

"Patients are our first priority and we are committed to providing L-MTP- PE to those who desperately need treatment," said Timothy P. Walbert, president and chief executive officer, IDM Pharma. "The potential survival and quality of life benefits for patients treated with L-MTP-PE continue to be supported through physician experience and we remain committed to advancing L- MTP-PE through the European and U.S. regulatory processes to bring this important treatment to market."

Update on L-MTP-PE Regulatory Status

In January 2008 the Company announced that following presentation of data at an oral explanation hearing before the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, the CHMP determined in a non-binding opinion that L-MTP-PE suggested a possible clinical benefit in terms of survival and granted the Company a clock stop, or time extension. The clock stop allows the Company additional time to respond to all the remaining questions regarding the marketing authorization application for L-MTP-PE (MAA). The CHMP has requested clarification of the existing data in order to gain assurance about the quality of the data before drawing any final conclusions from the data presented. In addition, the Company is required to address a number of remaining questions relating to chemistry, manufacturing and controls (CMC) and the Company expects to provide responses and data regarding these issues to the CHMP in advance of its meeting scheduled for June 23-26, although the CHMP may have additional questions or require additional information regarding these issues. In April, the European regulatory authorities conducted an inspection of the Children's Oncology Group (COG) to assess the quality of the overall survival data from the 2006 confirmatory database included in our applications for regulatory approval, and to review Good Clinical Practices compliance of COG in terms of patient randomization and stratification, overall survival data collection, and study monitoring. The Company supported the COG in this effort.

The Company expects to receive a final opinion from the CHMP in the third quarter and a final decision from the European Commission in the fourth quarter of 2008.

As previously announced, in the United States the Company continues to work with the COG as well as external experts and advisors to gather patient follow up data from the Phase 3 clinical trial of L-MTP-PE and to respond to other questions in the non-approvable letter the Company received from the U.S. Food and Drug Administration (FDA). The Company expects to submit the amended New Drug Application (NDA) in the fourth quarter of 2008.

L-MTP-PE was granted orphan drug status in the United States in 2001 and in Europe in 2004. In Europe, the MAA was filed in November 2006 and in the U.S, the NDA was submitted to FDA in October 2006 and was accepted for review in December 2006.

ABOUT OSTEOSARCOMA

Between two and three percent of all childhood cancers are osteosarcoma. Because osteosarcoma usually develops from osteoblasts, it most commonly affects children and young adults experiencing their adolescent growth spurt. Boys and girls have a similar incidence rate until later in their adolescence, when boys are more commonly affected. While most tumors occur in larger bones, such as the femur, tibia, and humerus, and in the area of the bone that has the fastest growth rate, they can occur in any bone. The most common symptom is pain, but swelling and limited movement can occur as the tumor grows.

Osteosarcoma is an orphan disease with fewer than 1,000 new cases diagnosed in the United States each year. A similar incidence of the disease exists in Europe. According to the Children's Oncology Group, the survival of children with osteosarcoma has remained at 60-65 percent since the mid-1980s. The standard treatment for osteosarcoma is tumor resection with combination chemotherapy before and after surgery.

IVOICE INCORPORATED (OTCBB: IVOI)
"Up 100.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/IVOI.php

iVoice, Inc., through its subsidiary Thomas Pharmaceuticals, Ltd., engages in the development and marketing of over the counter non-prescription healthcare products. It also involves in patent licensing. iVoice offers calcium-enriched, sugar free, and anti-gas antacid tablets targeted to travelers, executives, and baby boomers requiring antacid relief. The company, formerly known as Visual Telephone International, Inc., was incorporated in 1995. It changed its name to iVoice.com, Inc. in 1999 and to iVoice, Inc. in 2001. The company is headquartered in Matawan, New Jersey.

IVOI News:

May 14 - iVoice Redeems $4.8 Million in Secured Debenture Notes, Improves Balance Sheet

iVoice, Inc. (OTCBB: IVOI) announced that it has redeemed $4,796,510.00 million in Secured Convertible Debenture Notes that were previously issued to Cornell Capital Partners, LP. After repayment, there is currently $1,250,000.00 million plus accrued interest outstanding.

“We believe the redemption eliminates expensive debt that had the potential to be dilutive to shareholders,” said Jerry Mahoney, CEO of iVoice. “The repayment of this debt improves our balance sheet and reduces an overhang in our stock.”

ACTIONVIEW INTERNATIONAL INCORPORATED (OTCBB: AVWI)
"Up 25.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/AVWI.php

ActionView International's operating subsidiary custom-designs, develops, and manufactures vividly illuminated motion billboards. ActionView places its signs into high traffic locations and markets advertising space on the signs. ActionView shares advertising revenue generated from the billboards with advertising agencies, the local business partner and the location owner. The benefit to advertisers is exposure in high traffic locations at reasonable costs due to the scrolling feature and multiple advertisers. For additional information about ActionView, visit www.actionviewinternational.com.

AVWI News:

May 15 - ActionView International, Inc. CEO Discusses Letter of Intent for Acquisition Transaction With Jim Palmer Trucking, Inc.

ActionView International, Inc. (OTCBB: AVWI) CEO Steven R. Peacock discussed the company's recently announced letter of intent for an acquisition transaction with Jim Palmer Trucking, Inc., a leading transportation company headquartered in Missoula, Montana. ActionView International had been evaluating acquisition candidates for several months before entering into the agreement with Jim Palmer Trucking.

"It was our intention from the time we first became involved with ActionView International to target the best possible acquisition candidate," commented Mr. Peacock. "During this process, we were presented with and conducted due diligence on a number of private companies that were seeking acquisition by a public company. While the disclosure of specific financial information for Jim Palmer Trucking will be part of the closing process, we can say that ActionView management is confident that Jim Palmer Trucking is a high quality company that we believe has a tremendous future operating in the public markets."

"The timeline for this acquisition is expected to be relatively short, with the close expect within 60 days of the announced letter of intent. We look forward to providing as much information as possible over the next several weeks regarding the details of the transaction and the future of the public company with Jim Palmer Trucking as its focus," added Mr. Peacock.

Jim Palmer Trucking was established in 1966 with one truck and has grown into one of the premier refrigerated carriers in the United States. Jim Palmer Trucking operates in 44 states and maintains a fleet of 350 trucks and 500 trailers.

Jim Palmer Trucking's top five customers by percentage of revenues include Anheuser Busch, the Kroger Co., Coors Brewing Company, C.H. Robinson Worldwide, and Tyson Foods. In addition to its headquarters in Missoula, Montana, Jim Palmer Trucking has terminals in Salina, Kansas and Denver, Colorado. Jim Palmer Trucking also has drop lots located in Fontana, California; Tampa, Florida; Portland, Oregon; Wenatchee, Washington; and Chicago, Illinois.

The initial agreement in the form of a letter of intent provides the framework for a subsequent definitive agreement under which ActionView International would acquire all of the issued and outstanding shares of Jim Palmer Trucking, Inc. in exchange for a majority percentage of ActionView International. The details of the proposed share exchange will be included in the definitive agreement.

The letter of intent outlines additional due diligence, audit work and other terms that must be fulfilled to proceed to definitive agreement and to subsequently effect a close of the transaction.

The post-merger plan for Jim Palmer Trucking includes a potential acquisition strategy, the addition of new members to the management team, and the development of additional business lines within the trucking industry while maintaining and growing existing accounts in its core business.

CANNON EXPLORATION INCORPORATED (OTC: CNEX)
"Up 53.06% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CNEX.php

China Shuangji Cement Corporation, through its interest in Shandong Zhaoyuan Shuangji Group, Ltd., operates in the cement industry in the People's Republic of China and internationally. It offers portland cement and other cement products, which are used in the construction of buildings, roads, and other infrastructure projects. The company, formerly known as Citisource, Inc., was founded in 1983 and is based in Kent, the People's Republic of China.

CNEX News:

May 12 - Cannon Exploration Inc. Announces LOI to Acquire Gold Property

Cannon Exploration Inc. (OTC: CNEX) announced that it has entered into a Letter of Intent (LOI) agreement with IPMG Inc., an Ontario mineral resource exploration company, whereby IPMG has agreed to grant to Cannon Exploration Inc. an option to purchase up to 100% interest in the old "Queen Alexandria" gold mine, located in Northern Ontario.

The transaction is subject to a number of terms and conditions, including but not limited to, completion of satisfactory due diligence and the execution of a definitive option agreement.

SOUTHWALL TECHNOLOGIES INCORPORATED (OTCBB: SWTX)
"Up 37.65% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/SWTX.php

Southwall Technologies, Inc. develops, manufactures, and markets thin film coatings on flexible substrates for the automotive glass, electronic display, architectural glass, and applied window film markets. It develops various products that control sunlight in automotive glass, reduce light reflection, reduce electromagnetic radiation and improve image quality in electronic display products, and conserve energy via the application of architectural and after-market window film products. The company's products consist of transparent solar-control films for automotive glass; anti reflective films for computer screens, including flat panel displays and plasma displays; transparent conductive films for use in touch screen and liquid crystal displays; energy control films for architectural glass; and various other coatings. Southwall Technologies sells its products to original equipment manufacturers worldwide through direct sales force and sales representatives. The company was founded in 1979 and is based in Palo Alto, California.

SWTX News:

May 15 - Southwall Announces Q1 2008 Results

Demand for Energy Conservation Products Drives Improved Operating Margin in First Quarter

Southwall Technologies Inc. (OTCBB: SWTX) announced first quarter 2008 revenue of $10.6 million, up 21% from the fourth quarter of 2007 and up approximately 1% from the first quarter of 2007. The increase year over year was primarily due to higher sales of Automotive products, which more than offset the decline in revenue relating to Plasma Display product sales resulting from the Company’s decision to exit that business and focus on its core energy conservation products.

Net income increased to $2.0 million, or $.06 per fully diluted share, compared to net income of $0.2 million, or earnings of $0.00 per fully diluted share, in the first quarter of 2007. First quarter 2008 gross margins increased to 46% of sales from 42% in the first quarter of 2007 on a shift in product mix to higher margin energy conversation products and improved operating efficiencies. Operating margins increased to 20% of sales from 5% due to cost reduction efforts begun last year to more closely align the Company’s operating expenses with its strategic objectives. Overall, operating expenses decreased $1.1 million, or 29%, year over year.

Dennis Capovilla, Southwall’s President said of the Q1 results, “We believe that we are well positioned for growth in our core energy markets, where our products enable a new level of energy efficiency for green building and automotive designs. The recent increase in sales for our energy conservation products follows a growing global trend, highlighting consumer awareness that energy conservation is an efficient, effective and readily-available renewable technology choice that can have an immediate impact on saving energy and reducing carbon emissions.”

PILGRIM PETROLEUM CORPORATION (OTC: PGPM)
"Up 60.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PGPM.php

Pilgrim Petroleum Corporation is a publicly traded company headquartered in Dallas, Texas. The company is acquiring oil and gas leases, producing properties, mineral rights and surface interest's primary on marginal fields. Once acquired, the company intends to develop each property to maximize the income from each by refurbishing and improving the existing production.

PGPM News:

May 12 - Pilgrim Petroleum Announces Projected EPS for 2008

Pilgrim Petroleum Corporation (OTC: PGPM) (Frankfurt: PHV.F) announced the company's year 2008 projected EPS (Net Earnings / Outstanding Shares) $50,000,000/844,236,923 of 0.06. Based on this EPS multiplied by a sustainable growth rate of 25% and multiplied by the average industry P/E ratio of 20.96 (Reuters), Pilgrim's intrinsic value or estimated stock value should be $0.3103.

Pilgrim Petroleum's prime properties are mainly located in the North West Texas, owning approximately 12,000 acre properties, which hosts resources with a best estimate P50 (*) of 4 millions of barrels of oil equivalent, definitions according to "Petroleum Classification and Definitions" (2000) published in draft by the Society of Petroleum Engineers (SPE) and World Petroleum Congress. The already on-going next phase is to strategize with its Partners and alliances for new drilling activities in its leasehold position for further categorization of reserves, including development and production status (proved, probable and possible).

Pilgrim Petroleum management is currently focused on developing multiple horizons with hydrocarbon potential and is proud to communicate that the company's combined assets are now producing in an upward trend and new acquisitions for further hydrocarbon development under consideration.

Rafael Pinedo, President of Pilgrim Petroleum Corporation, commented, "Triple digit oil prices and current market conditions make new ventures an open opportunity to develop our assets with great levels of profitability. Management is implementing streamlining operations activities as well as targeting new acquisitions and joint ventures.”

RAM GOLD & EXPLORATION INCORPORATED (OTC: RMGX)
"Up 40.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/RMGX.php

Ram Gold & Exploration, Inc., an early-stage mining company, engages in the exploration and production of precious metals. It focuses on gold and silver minerals in areas, such as Arizona, Oregon, California, British Columbia, and the Yukon Territories, as well as South America. The company is based in Las Vegas, Nevada.

RMGX News:

May 15 - RAM Gold & Exploration, Inc. Announces Contract Negotiations

Ram Gold & Exploration, Inc. (OTC: RMGX), formerly Gaia Resources, Inc., announced that it has completed contract negotiations with AMR Project Peru, S.A.C. relating to its Letter of Intent between the parties in order to begin drilling and exploration on the AMR property with the intent to commercialize the properties operations.

In December 2007, RAM Gold entered into a letter of intent with AMR Project Peru, S.A.C., (AMR), to acquire and develop certain mining leasehold interests held in Peru. AMR owns certain mining and concession rights to 500 hectares of land in northern Peru. Because the name AMR could be perceived to be somewhat confusing with other U.S. companies having similar names derivations, the Company decided to utilize the letters AMR but change the order of the letters to RAM in the formation of its new corporate name.

It is the intent of the Company to explore, develop, operate and put the AMR property into production. The AMR property is in an exploration and development stage and mineral reserves have not been amply substantiated and additional exploration and drilling must be realized to better ascertain the mines potential reserve values.

RAM Gold’s common shares are quoted on OTC Pinksheets at www.pinksheets.com under the symbol “RMGX” and the Frankfurt Stock Exchange under the Symbol “XYO”. Further information, a brief executive summary and a geological study of the project is provided as an exhibit to the RAM Gold's corporate disclosure statement as found at www.pinksheets.com together with a geological study relating to the same and assay reports of samplings of concentrated black sands derived from the property.

RMGX believes that the prospect for this property appears to be very positive though not yet proven. The mine property is found near the District of Ayapata, province of Carabaya, Department of Puno, Peru.

RAM Gold's website is currently under construction.

MILLENNIUM CELL INCORPORATED (NASD: MCEL)
"Up 47.59% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MCEL.php

Millennium Cell, Inc., a development stage company, develops hydrogen batteries for use primarily in portable electronic devices for the military, medical, industrial, and consumer markets. The hydrogen batteries comprise a fuel cell and hydrogen storage technology. The fuel blends used in the hydrogen battery technology include combination of water, sodium borohydride, and other chemicals. The hydrogen produced by its hydrogen fuel cartridge technology is converted into electricity by a fuel cell. The company develops the technology in partnership with corporate and government entities. It also licenses its hydrogen cartridge technology and designs to companies, which develop fuel cell systems. Millennium Cell has a strategic relationship with The Dow Chemical Company for the commercialization of its hydrogen battery technology in the military and consumer electronics markets, as well as has a joint development and licensing agreement with Horizon Fuel Cells Plc. The company was founded in 1998 and is based in Eatontown, New Jersey.

MCEL News:

May 12 - Millennium Cell Updates Stakeholders

Millennium Cell Inc. (NASD: MCEL), a leading developer of hydrogen battery technology, announced that its Board of Directors has terminated the employment of all executive officers and employees of the Company effective as of the close of business on Friday, May 9, and has ceased operations. The Company has advised its employees of a possible recall offer for employment if immediate cash funding in an amount sufficient to restart operations becomes available.

The Executive Committee of the Board of Directors and certain members of senior management who are serving on a voluntary basis are engaged in discussions with a corporation that has expressed interest in entering into a reverse merger transaction with the Company, which would provide short term liquidity to the Company pending completion. That transaction will require, among other things, that the Company's common stock remain listed on the NASDAQ and that the Company restructure its existing convertible debentures in a principal amount of approximately $4.1 million after recent conversions. The Company is scheduled to present a plan of compliance to NASDAQ at a hearing on June 12, 2008.

The Company cannot provide any assurances that it will be able to complete this transaction or any other one which would provide an immediate source of cash. Without such a transaction and funding occurring in the very near term, the Company may be subject to a Bankruptcy proceeding.

ICP SOLAR TECHNOLOGIES (OTCBB: ICPR)
"Up 21.11% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ICPR.php

ICP Solar is a developer, manufacturer and marketer of solar panels and solar cell based products and building materials. Through the application of next-generation technologies and use of proprietary intellectual design the Company aims to be the industry's innovation leader. For the past 19 years, ICP Solar has led the consumer market through innovation and has now begun to apply that same philosophy to the OEM, rooftop and power generation segment of the solar industry. ICP Solar's management has over 50 years of experience in the renewable energy sector. ICP Solar is the North American licensee of the Coleman® brand in the solar charger category. The company’s headquarters are located in Montreal, Canada, with additional locations in the USA, Spain, Ireland and France.

ICPR News:

May 15 - ICP Solar Expands Distribution in Nordic Countries

Sunsei® product line helps bring solar energy into Northern Europe outdoor lifestyle

ICP Solar Technologies Inc. (OTCBB: ICPR) (Frankfurt: K1U.F), a developer, manufacturer and marketer of solar panels and products, announced that is has appointed EnergyGross as its distribution partner in Finland and Sweden.

EnergyGross is a distributor of specialized energy saving, green, eco solutions. Their product portfolio includes wind turbines, hydro power solutions, solar heaters, heat exchanges, energy efficient LED lamps and rechargeable batteries by SANYO.

“The Nordic countries are world leaders in the use of both renewable energy and alternative fuels,” stated Pascal Petit, ICP Solar’s VP of Sales- Europe and Asia Pacific. “This is a market where people are very aware of their environment and have quickly embraced the use of alternative fuels and renewable energy so the demand for our products is high. We are thrilled to be working with EnergyGross in order to be able to provide Nordic consumers with the entire Sunsei® range of solar products.”

“The Nordic people have always embraced the outdoor life. Sailing and camping are a integral part of our culture,” stated Harri af Hällström, MD of EnergyGross. “Sunsei® solar products are the most innovative and reliable products of their kind. Their portability, reliability and designs will be quickly embraced and become a part of everyone’s camping or sailing adventures. We look forward to a long and productive relationship with ICP Solar as we continue to build awareness of alternative energy technologies and the Sunsei® brand.”

ABOUT ENERGYGROSS

EnergyGross is specialized in energy saving green eco solutions for the mass market. Its portfolio includes smaller size wind turbines, water power, solar heaters, heat exchanges, new efficient LED lamps, new efficient rechargeable batteries.

Corporate information may be found at www.icpsolar.com and www.energygross.se.